During the last session, Bionomics Ltd. ADR (NASDAQ:BNOX)’s traded shares were 0.48 million, with the beta value of the company hitting -0.07. The 52-week high for the BNOX share is $2.84, that puts it down -1320.0 from that peak though still a striking 10.0% gain since the share price plummeted to a 52-week low of $0.18. The company’s market capitalization is $2.61M, and the average intraday trading volume over the past 10 days was 3.1 million shares, and the average trade volume was 699.35K shares over the past three months.
Bionomics Ltd. ADR (BNOX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. BNOX has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bionomics Ltd. ADR (NASDAQ:BNOX) trade information
Bionomics Ltd. ADR (BNOX) registered a -1.06% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.06% in intraday trading to $0.20, hitting a weekly high. The stock’s 5-day price performance is -20.22%, and it has moved by -29.17% in 30 days. Based on these gigs, the overall price performance for the year is -91.96%. The short interest in Bionomics Ltd. ADR (NASDAQ:BNOX) is 13778.0 shares and it means that shorts have 0.05 day(s) to cover.
The consensus price target of analysts on Wall Street is $6, which implies an increase of 96.67% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6 and $6 respectively. As a result, BNOX is trading at a discount of -2900.0% off the target high and -2900.0% off the low.
Bionomics Ltd. ADR (BNOX) estimates and forecasts
Statistics show that Bionomics Ltd. ADR has outperformed its competitors in share price, compared to the industry in which it operates. Bionomics Ltd. ADR (BNOX) shares have gone down -79.49% during the last six months, with a year-to-date growth rate more than the industry average at 18.08% against 17.10.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 14.53%. While earnings are projected to return -15.00% in 2024.
BNOX Dividends
Bionomics Ltd. ADR is due to release its next quarterly earnings on 2022-Aug-29. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 0.6 million shares, is of LYNX1 CAPITAL MANAGEMENT LP’s that is approximately 6.3212% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $0.46 million.
